Acute effect of cyclosporin on renal function following the initial changeover to a microemulsion formulation in stable kidney transplant patients

Transplant International - Tập 8 Số 5 - Trang 335-339 - 1995
John M. Kovarik1, Z Kállay1, Edgar A. Mueller1, J B van Bree2, Wolfgang Arns3, E. Renner3
1Department of Clinical Pharmacology (386/907A), Sandoz Pharma Ltd., CH-4002 Basel, Switzerland Fax: + 41 61 324 2959
2Department of Drug Metabolism and Pharmacokinetics, Sandoz Pharma Ltd., CH-4002 Basel, Switzerland
3Internal Medicine Clinic, City Hospital Cologne-Merheim, Cologne, Germany

Tóm tắt

Từ khóa


Tài liệu tham khảo

Ball PE, Munzer H, Keller HP, Abisch E, Rosenthaler J (1988) Specific 3H radioimmunoassay with a monoclonal antibody for monitoring cyclosporine in blood. Clin Chem 34: 257?260

Bennett WM (1990) Renal effects of cyclosporine. J Am Acad Dermattol 23: 1280?1287

Buijsen JGM, Acker BAC van, Koomen GCM, Koopman MG, Arisz L (1994) Circadian rhythm of glomerular filtration rate in patients after kidney transplantation. Nephrol Dial Transplant 9: 1330?1333

DuBois EF (1927) Basal metabolism in health and disease Lea and Febiger, Philadelphia

Kovarik JM, Mueller EA, Bree JB van, Flückiger S, Lange H, Schmidt B, Boeskin WH, Lison AE, Kutz K (1994) Cyclosporine pharmacokinetics and variability from a microemulsion formulation: a multicenter investigation in kidney transplant patients. Transplantation 58: 658?663

Lubowitz H, Slatopolsky E, Schankel S, Rieselbach RE, Bricker NS (1967) Glomerular filtration rate: determination in patients with chronic renal disease. JAMA 199: 252?256

Luke DR, Halstenson CE, Opsahl JA, Matzke GR (1990) Validity of creatinine clearance estimates in the assessment of renal function. Clin Pharmacol Ther 48: 503?508

Mertz DP (1963) Observations on renal clearance and the volume of distribution of polyfructosan S, a new inulinlike substance. Experientia 19: 1?3

Mueller EA, Kovarik JM, Bree JB van, Lison AE, Kutz K (1994) Pharmacokinetics and tolerability of a microemulsion formulation of cyclosporine in renal allograft recipients: a concentrationcontrolled comparison with the commercial formulation. Transplantation 57: 1178?1182

Perico N, Ruggenenti P, Gaspari F, Mosconi L, Benigni A, Amuchastegui CS, Gasparini F, Remuzzi G (1992) Daily hypoperfusion induced by cyclosporine in patients with renal transplantation. Transplantation 54: 56?60

Schück O, Matl J, Nadvornikova H, Teplan V, Skibova J (1992) Cyclosporine A treatment and evaluation of glomerular filtration rate in patients with a transplanted kidney. Int J Clin Pharmacol Ther Toxicol 30: 195?201

Taesch S, Niese D (1994) Safety and tolerability of a new oral formulation of cyclosporin A, Sandimmun Neoral, in renal transplant patients. Transpl Int S263?S266